Does routine CYP2D6 and CYP2C19 genotyping reduce the risk of adverse events related to antipsychotic drug treatment?

Gesche Jürgens; Stig Ejdrup Andersen; Heidi Jensen; Henrik Berg Rasmussen; Thomas Mears Werge; Merete Nordentoft

Does routine CYP2D6 and CYP2C19 genotyping reduce the risk of adverse events related to antipsychotic drug treatment?

Gesche Jürgens, Stig Ejdrup Andersen, Heidi Jensen, Henrik Berg Rasmussen, Thomas Mears Werge, Merete Nordentoft

Originalsprog	Engelsk
Tidsskrift	Clinical Toxicology
Vol/bind	51
Udgave nummer	4
Sider (fra-til)	325-325
Antal sider	1
ISSN	1556-3650
Status	Udgivet - 2013

Citationsformater

@article{05acfd8dff884ba4bd398eab9fe3c384,

title = "Does routine CYP2D6 and CYP2C19 genotyping reduce the risk of adverse events related to antipsychotic drug treatment?",

author = "Gesche J{\"u}rgens and Andersen, {Stig Ejdrup} and Heidi Jensen and Rasmussen, {Henrik Berg} and Werge, {Thomas Mears} and Merete Nordentoft",

year = "2013",

language = "English",

volume = "51",

pages = "325--325",

journal = "Clinical Toxicology",

issn = "1556-3650",